Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

1.

High-efficiency transfection of primary human and mouse T lymphocytes using RNA electroporation.

Zhao Y, Zheng Z, Cohen CJ, Gattinoni L, Palmer DC, Restifo NP, Rosenberg SA, Morgan RA.

Mol Ther. 2006 Jan;13(1):151-9. Epub 2005 Sep 2.

2.

Primary human lymphocytes transduced with NY-ESO-1 antigen-specific TCR genes recognize and kill diverse human tumor cell lines.

Zhao Y, Zheng Z, Robbins PF, Khong HT, Rosenberg SA, Morgan RA.

J Immunol. 2005 Apr 1;174(7):4415-23.

3.
4.

High transfection efficiency of porcine peripheral blood T cells via nucleofection.

Zhao X, Su H, Yin G, Liu X, Liu Z, Suo X.

Vet Immunol Immunopathol. 2011 Dec 15;144(3-4):179-86. doi: 10.1016/j.vetimm.2011.10.003. Epub 2011 Oct 15.

PMID:
22055481
5.

Activation of tumor-specific T cells by dendritic cells expressing the NY-ESO-1 antigen after transfection with the cationic lipophosphoramide KLN5.

Le Gallo M, Toutirais O, Montier T, Cabillic F, Bouet F, Delépine P, Lehn P, Jotereau F, Catros V.

J Gene Med. 2008 Jun;10(6):628-36. doi: 10.1002/jgm.1188.

PMID:
18338820
6.

Gene transfer of tumor-reactive TCR confers both high avidity and tumor reactivity to nonreactive peripheral blood mononuclear cells and tumor-infiltrating lymphocytes.

Johnson LA, Heemskerk B, Powell DJ Jr, Cohen CJ, Morgan RA, Dudley ME, Robbins PF, Rosenberg SA.

J Immunol. 2006 Nov 1;177(9):6548-59.

7.

Enhanced receptor expression and in vitro effector function of a murine-human hybrid MART-1-reactive T cell receptor following a rapid expansion.

Goff SL, Johnson LA, Black MA, Xu H, Zheng Z, Cohen CJ, Morgan RA, Rosenberg SA, Feldman SA.

Cancer Immunol Immunother. 2010 Oct;59(10):1551-60. doi: 10.1007/s00262-010-0882-5. Epub 2010 Jul 14.

8.

High-level transgene expression in primary human T lymphocytes and adult bone marrow CD34+ cells via electroporation-mediated gene delivery.

Van Tendeloo VF, Willems R, Ponsaerts P, Lenjou M, Nijs G, Vanhove M, Muylaert P, Van Cauwelaert P, Van Broeckhoven C, Van Bockstaele DR, Berneman ZN.

Gene Ther. 2000 Aug;7(16):1431-7.

9.

Selective modification of antigen-specific T cells by RNA electroporation.

Mitchell DA, Karikari I, Cui X, Xie W, Schmittling R, Sampson JH.

Hum Gene Ther. 2008 May;19(5):511-21. doi: 10.1089/hum.2007.115.

10.

Generation of antigen-presenting cells using cultured dendritic cells and amplified autologous tumor mRNA.

Minami K, Yamaguchi Y, Ohshita A, Kawabuchi Y, Ohta K, Hihara J, Toge T.

Oncology. 2005;69(5):399-407. Epub 2005 Nov 24.

PMID:
16319511
11.

Gene transfer of human TCR in primary murine T cells is improved by pseudo-typing with amphotropic and ecotropic envelopes.

Pouw NM, Westerlaken EJ, Willemsen RA, Debets R.

J Gene Med. 2007 Jul;9(7):561-70.

PMID:
17471588
12.

High efficiency TCR gene transfer into primary human lymphocytes affords avid recognition of melanoma tumor antigen glycoprotein 100 and does not alter the recognition of autologous melanoma antigens.

Morgan RA, Dudley ME, Yu YY, Zheng Z, Robbins PF, Theoret MR, Wunderlich JR, Hughes MS, Restifo NP, Rosenberg SA.

J Immunol. 2003 Sep 15;171(6):3287-95.

13.

Immunity and protection by adoptive transfer of dendritic cells transfected with hepatitis C NS3/4A mRNA.

Yu H, Babiuk LA, van Drunen Littel-van den Hurk S.

Vaccine. 2007 Feb 26;25(10):1701-11. Epub 2006 Dec 5.

PMID:
17240490
14.

Enhanced dendritic cell antigen presentation in RNA-based immunotherapy.

Kalady MF, Onaitis MW, Padilla KM, Emani S, Tyler DS, Pruitt SK.

J Surg Res. 2002 Jun 1;105(1):17-24.

PMID:
12069496
15.

Human dendritic cells transfected with either RNA or DNA encoding influenza matrix protein M1 differ in their ability to stimulate cytotoxic T lymphocytes.

Strobel I, Berchtold S, Götze A, Schulze U, Schuler G, Steinkasserer A.

Gene Ther. 2000 Dec;7(23):2028-35.

16.

Single and dual amino acid substitutions in TCR CDRs can enhance antigen-specific T cell functions.

Robbins PF, Li YF, El-Gamil M, Zhao Y, Wargo JA, Zheng Z, Xu H, Morgan RA, Feldman SA, Johnson LA, Bennett AD, Dunn SM, Mahon TM, Jakobsen BK, Rosenberg SA.

J Immunol. 2008 May 1;180(9):6116-31.

17.

Efficient simultaneous presentation of NY-ESO-1/LAGE-1 primary and nonprimary open reading frame-derived CTL epitopes in melanoma.

Rimoldi D, Rubio-Godoy V, Dutoit V, Lienard D, Salvi S, Guillaume P, Speiser D, Stockert E, Spagnoli G, Servis C, Cerottini JC, Lejeune F, Romero P, Valmori D.

J Immunol. 2000 Dec 15;165(12):7253-61.

18.

Truncated TERT mRNA transfected dendritic cells evoke TERT specific antitumor response in vivo.

Qiu J, Lil GW, Sui YF, Sun YJ, Huang YY, Si SY, Ge W, Song HP.

Hepatogastroenterology. 2007 Apr-May;54(75):681-7.

PMID:
17591041
19.

Human T cells expressing two additional receptors (TETARs) specific for HIV-1 recognize both epitopes.

Hofmann C, Höfflin S, Hückelhoven A, Bergmann S, Harrer E, Schuler G, Dörrie J, Schaft N, Harrer T.

Blood. 2011 Nov 10;118(19):5174-7. doi: 10.1182/blood-2011-04-347005. Epub 2011 Sep 16.

20.

[Blocking the escape of leukemic cells from killing of T cell by combining anti-Fas ribozyme and CD80-IgG fusion protein].

Liu LB, Li WM, He W, Zhang M, Xiao J, Zhong ZD, Li L, Zou P.

Zhonghua Yi Xue Za Zhi. 2005 Dec 28;85(49):3469-74. Chinese.

PMID:
16686062

Supplemental Content

Support Center